Arkolith/Insider Trading/GMTX/Form 4

Meyenburg Jason Patrick

President & CEO, DirectorGemini Therapeutics, Inc. /DE (GMTX) · full profile →Form 4 · filed May 18, 2021
Net Buying
Open-Market Buys
$123K
Open-Market Sells
$0
Net Open-Market Flow
$123K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2021Buy(P)13K$9.46$123K13K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-019762) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML